Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
233 |
|
| Actual shortage: | 5 (2%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 3 (1%) | |
| Resolved: | 223 (96%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 2 (7%) | |
| Discontinued: | 27 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
14 (5%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IFEX | 3G | POWDER FOR SOLUTION | Resolved | 2020-06-08 | 2020-06-23 | 116977 |
| IFEX | 3G | POWDER FOR SOLUTION | Anticipated shortage | 2025-12-03 | 2025-12-03 | 273129 |
| IFEX | 1G | POWDER FOR SOLUTION | Resolved | 2020-04-23 | 2020-05-13 | 113046 |
| IFEX | 1G | POWDER FOR SOLUTION | Resolved | 2020-08-27 | 2020-09-02 | 123045 |
| IFEX | 1G | POWDER FOR SOLUTION | Resolved | 2023-09-08 | 2023-10-10 | 203950 |
| IFEX | 1G | POWDER FOR SOLUTION | Anticipated shortage | 2025-12-03 | 2025-12-03 | 273126 |
| IFEX | 1G | POWDER FOR SOLUTION | Resolved | 2017-06-01 | 2017-08-28 | 11683 |
| IFEX | 1G | POWDER FOR SOLUTION | Resolved | 2017-08-28 | 2017-10-06 | 20433 |
| IFEX | 3G | POWDER FOR SOLUTION | Resolved | 2019-01-14 | 2019-02-05 | 72133 |
| IFEX | 3G | POWDER FOR SOLUTION | Resolved | 2020-01-16 | 2020-02-05 | 103465 |
| IFEX | 3G | POWDER FOR SOLUTION | Resolved | 2020-04-02 | 2020-04-21 | 110477 |
| LACTATED RINGER'S INJECTION, USP | 20MG 30MG 310MG 600MG | SOLUTION | Resolved | 2022-04-12 | 2022-04-21 | 158687 |
| LACTATED RINGER'S INJECTION, USP | 20MG 30MG 310MG 600MG | SOLUTION | Resolved | 2022-08-24 | 2022-10-25 | 167745 |
| LACTATED RINGER'S INJECTION, USP | 310MG 20MG 30MG 600MG | SOLUTION | Resolved | 2019-03-15 | 2019-03-30 | 78800 |
| LACTATED RINGER'S INJECTION, USP | 310MG 20MG 30MG 600MG | SOLUTION | Resolved | 2019-04-02 | 2019-05-02 | 80329 |
| 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION | 50MG 4MG | SOLUTION | Resolved | 2019-10-04 | 2019-11-19 | 95574 |
| 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION | 50MG 4MG | SOLUTION | Resolved | 2019-12-19 | 2020-01-28 | 101629 |
| METRONIDAZOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2019-01-02 | 2019-02-09 | 70778 |
| METRONIDAZOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2019-06-18 | 2019-07-03 | 86984 |
| METRONIDAZOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2019-07-16 | 2019-08-09 | 89429 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLINIMIX E | 90MG 210MG 20MG 261MG 58.5MG 24MG 205MG 20G 310MG 310MG 290MG 290MG 1.04G 1.04G 520MG 240MG 230MG 220MG 210MG | SOLUTION | Discontinued | 2020-06-22 | 2021-03-26 | 118604 |
| CLINIMIX E | 205MG 261MG 58.5MG 24MG 16.6G 365MG 280MG 290MG 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG | SOLUTION | Discontinued | 2020-06-22 | 2022-06-30 | 118607 |
| CLINOLEIC 20% | 4% 16% | EMULSION | Discontinued | 2017-04-04 | 2018-01-01 | 5289 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91378 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91382 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91385 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 900MG 300MG | SOLUTION | Discontinued | 2020-11-26 | 2021-02-02 | 128947 |
| PROCYTOX | 200MG | POWDER FOR SOLUTION | To be discontinued | 2025-08-14 | 2025-08-14 | 265253 |
| PROCYTOX TAB 25MG | 25MG | TABLET | To be discontinued | 2025-08-14 | 2025-08-14 | 265250 |